Perspectives on the Treatment of Malignant Pleural Mesothelioma.
Janes SM, Alrifai D, Fennell DA.
N Engl J Med. 2021 Sep 23;385(13):1207-1218. doi: 10.1056/NEJMra1912719.
Pleural mesothelioma classification-update and challenges.
Dacic S.
Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31.
The Molecular Basis of Malignant Pleural Mesothelioma.
Wadowski B, De Rienzo A, Bueno R.
Thorac Surg Clin. 2020 Nov;30(4):383-393. doi: 10.1016/j.thorsurg.2020.08.005. Epub 2020 Sep 12.
New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.
Tsao AS, Pass HI, Rimner A, Mansfield AS.
J Clin Oncol. 2022 Feb 20;40(6):681-692. doi: 10.1200/JCO.21.01567. Epub 2022 Jan 5.
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM.
Eur Respir J. 2020 Jun 11;55(6):1900953. doi: 10.1183/13993003.00953-2019. Print 2020 Jun.
Malignant Pleural Mesothelioma.
Bois MC, Lee HE, Erickson LA.
Mayo Clin Proc. 2016 Jul;91(7):e103-4. doi: 10.1016/j.mayocp.2016.02.019.
Asbestos-associated pulmonary disease.
Caceres JD, Venkata AN.
Curr Opin Pulm Med. 2023 Mar 1;29(2):76-82. doi: 10.1097/MCP.0000000000000939. Epub 2023 Jan 11.
Malignant pleural mesothelioma: recent developments.
Sinn K, Mosleh B, Hoda MA.
Curr Opin Oncol. 2021 Jan;33(1):80-86. doi: 10.1097/CCO.0000000000000697.
Pathology of Malignant Pleural Mesothelioma.
Hung YP, Chirieac LR.
Thorac Surg Clin. 2020 Nov;30(4):367-382. doi: 10.1016/j.thorsurg.2020.08.007.
Pleural mesothelioma classification update.
Beasley MB, Galateau-Salle F, Dacic S.
Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.
